AI-developed drug will be in trials by year-end, says Google’s Hassabis
Isomorphic was spun out of Google’s AI research arm Google DeepMind in 2021, but remains a wholly owned subsidiary of its parent company, Alphabet. The start-up’s potential has attracted big pharmaceutical partners, which are keen to lower expenses and boost efficiency of the costly drug development process.
Trials of drugs developed with AI could begin this year, Google DeepMind CEO says
The CEO of Google Mind has suggested clinical trials of the first drugs designed with the help of AI could begin this year.
Google-backed, AI-developed drugs are headed to trial by 2026, DeepMind CEO says
Drugs developed by Alphabet’s drug discovery subsidiary and designed by artificial intelligence are expected to head to trial by the end of the year, according to a Google (GOOGL) executive.
DeepMind’s Hassabis Sees AI-Designed Drug Trials This Year
Google DeepMind spinoff Isomorphic Labs expects research of drugs it designed using artificial intelligence will begin this year, according to its Nobel Prize-winning chief executive officer.
Wall Street Lunch: AI-Designed Drugs Expected To See Trials This Year
Google's DeepMind spinoff Isomorphic Labs expects clinical trials of drugs designed using AI to start late this year.
Google DeepMind CEO says 2025's the year we start popping pills AI helped invent
Nobel Prize winner Demis Hassabis thinks human trials will happen soon Clinical trials of the first drugs designed with the help of artificial intelligence could commence this year, Google DeepMind CEO Demis Hassabis suggested Tuesday.
DeepMind expects clinical trials for AI-designed drugs this year
Google DeepMind spinoff Isomorphic Labs expects research of drugs it designed using artificial intelligence will begin this year, according to its Nobel Prize-winning chief executive officer. “We’ll hopefully have some AI-designed drugs in clinical trials by the end of the year,
Google's DeepMind eyes clinical trials for AI-designed drugs in 2025 - report
Google's DeepMind spinoff Isomorphic Labs expects clinical trial of drugs it designed using AI to start this year.
Europe accelerates AI drug discovery as DeepMind spinoff targets trials this year
Google DeepMind spinoff Isomorphic Labs expects testing on its first AI-designed drugs to begin this year, as tech startups race to turn algorithmic magic into actual treatments. “We’ll hopefully have
NextBigFuture12h
Demis Hassabis Thinks Searching Knowledge Is Needed for Superintelligent AI
Demis Hassabis is the CEO of Google DeepMind. Demis thinks new agent type systems will be able to perform additional tree of knowledge search to achieve ...
CNET on MSN20h
Samsung Galaxy S25 Ultra Hands On: AI Everywhere, Plus a Bigger Screen
Samsung's Galaxy S25 phones are all about AI. But the Ultra also gets a larger screen and a slightly refreshed look with ...
JD Supra10d
Key AI Leaders of 2024: Huang, Amodei, Kurzweil, Altman, and Nobel Prize Winners – Hassabis and Hinton
Introduction - The year 2024 marked a pivotal time in artificial intelligence, where aspirations transformed into concrete ...